Gene · 6510
SLC1A5: solute carrier family 1 member 5
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SLC1A5: solute carrier family 1 member 5. Genes, record 6510. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6510
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q15758 | Neutral amino acid transporter B(0) | 541 | 27 | Ensembl, GeneID, HGNC |
Source UniProt
Patents99
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| WO 2026134203 A | 2026-06-25 | 3 | Q15758 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 63955 | Q15758 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 16330 | Q15758 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 20015 | Q15758 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 1129 | Q15758 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 16547 | Q15758 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 4043 | Q15758 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 4043 | Q15758 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 20015 | Q15758 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 16330 | Q15758 | Espacenet |
1 to 10 of 99
See all 99 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,927
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SLC1A5 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 28 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 25 | 2025 |
| R01DK105550 | Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease | 9 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 8 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 7 | 2025 |
| R01ES010563 | Mechanisms of Manganese Neurotoxicity | 7 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 6 | 2025 |
| R01CA051497 | Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis | 6 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 5 | 2025 |
| P30CA030199 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
1 to 10 of 1,927Source NIH's project files
See all 1,927 nih grantsPapers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Digital Quantification of Membrane DAB Immunohistochemical Staining in FFPE Cervical Cancer Tissues Using an Open-Source CellProfiler Pipeline. | Bio Protoc | 2026 | 42780749 | PubTator, text mining | PubMed |
| Metabolic profiling of CAR T-cells in patients reveals a shift toward amino acid-supported OXPHOS and informs transporter engineering. | Res Sq | 2026 | 42780275 | PubTator, text mining | PubMed |
| Plasma Feeding Protects the Blood-Brain Barrier Post-Asphyxia While the Blood-CSF Barrier Remains Spared. | Stroke | 2026 | 42751786 | PubTator, text mining | PubMed |
| Amino acid transporters in hepatocellular carcinoma: Gatekeepers of metabolic reprogramming. | Mol Biol Rep | 2026 | 42747623 | PubTator, text mining | PubMed |
| Plumbagin Is a PKM2 Activator That Modulates Glutamine Metabolism and Dependency in Leukemia. | Metabolites | 2026 | 42646313 | PubTator, text mining | PubMed |
| MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistance. | Cell Death Differ | 2026 | 42601381 | PubTator, text mining | PubMed |
| Single-cell and functional profiling identifies an IL6-centered immunometabolic communication circuit in multiple myeloma. | Front Immunol | 2026 | 42577287 | PubTator, text mining | PubMed |
| Human M1 macrophages secrete glutamine: a role for the transporters ASCT2 and SNAT5. | Am J Physiol Cell Physiol | 2026 | 42575884 | PubTator, text mining | PubMed |
| METTL7A Downregulation Drives SLC1A5-Mediated Glutamine Competition to Promote Tumor Proliferation and Suppress CD8+ T Cell Immunity in Gastric Cancer. | Adv Sci (Weinh) | 2026 | 42544900 | PubTator, text mining | PubMed |
| PLK1-mediated phosphorylation of PHGDH reprograms serine metabolism in advanced prostate cancer. | Proc Natl Acad Sci U S A | 2026 | 42507939 | PubTator, text mining | PubMed |
1 to 10 of 3,624
See all 3,624 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6510
GET https://conductscience.org/api/genes/v1/6510/patents?page=2